Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Combination of anti-cancer drugs with molecular chaperone inhibitors
Maxim Shevtsov
,
Gabriele Multhoff
, Elena Mikhaylova
, Atsushi Shibata
, Irina Guzhova
, Boris Margulis
Associate Professorship of Experimental Radiation Oncology / Radiation Biology
Technical University of Munich
Institute of Cytology of the Russian Academy of Sciences
St. Petersburg State Medical Pavlov University
Almazov National Medical Research Centre
Federal University
National Center for Neurosurgery
Gunma University
Research output
:
Contribution to journal
›
Review article
›
peer-review
50
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combination of anti-cancer drugs with molecular chaperone inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticancer Drugs
100%
Tumor Cells
100%
Cellular Physiology
100%
Molecular Chaperone
100%
Chaperone Inhibitors
100%
Pathologic
50%
Cancer Cells
50%
Therapeutic Approaches
50%
Heat Shock Protein 90 (Hsp90)
50%
Environmental Stress
50%
Heat Shock Proteins
50%
Stress Factors
50%
Single Treatment
50%
Anticancer Therapy
50%
Protein Family
50%
Chaperone
50%
Heat Shock Protein 70 (HSP70)
50%
Proteotoxic Stress
50%
Optimal Dose
50%
Heat Shock Response
50%
Heat Shock Protein 27 (HSP27)
50%
Targeted Drugs
50%
Anticancer Therapeutics
50%
Inhibitor Drug
50%
Pharmacological Stress
50%
Medicine and Dentistry
Chaperone
100%
Anticarcinogen
100%
Neoplasm
66%
Cell Function
66%
Malignant Neoplasm
33%
Cancer Treatment
33%
Cancer Cell
33%
Heat Shock Response
33%
Drug Delivery System
33%
Protein Family
33%
Heat Shock Protein 27
33%
Heat Shock Protein
33%
Cytoprotective Agent
33%
Combination Drug
33%
Omeprazole
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Anticarcinogen
100%
Chaperone
100%
Neoplasm
66%
Drug Delivery System
33%
Omeprazole
33%
Cytoprotective Agent
33%
Heat Shock Protein
33%
Heat Shock Protein 27
33%
Combination Drug
33%